Alx Oncology Holdings Inc (NASDAQ:ALXO) traded at $1.81 at close of the session on Friday, January 03 and made an upward move of 16.03% on its previous day’s price.
Looking at the stock we see that its previous close was $1.56 and the beta (5Y monthly) reads 1.036 with the day’s price range being $1.56 – $1.8694. In terms of its 52-week price range, ALXO has a high of $17.83 and a low of $1.19. The company’s stock has gained about 16.77% over that past 30 days.
Alx Oncology Holdings Inc has a market cap of $110.77 million and is expected to release its quarterly earnings report in February.
On the other hand, looking at the outlook for the ALXO stock, short term indicators assign the stock an average of Hold, while medium term indicators assign it an average of 50% Sell.
Based on estimates by 5 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Alx Oncology Holdings Inc (ALXO) stock as a Hold, while 5 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 9.40% off its SMA20 and 18.84% from its 50-day simple moving average. The RSI (14) is pointing at 56.30 while the volatility over the past week is 11.70% and jumps to 13.41% over the past one month. The beta value is 0.98, while the average true range (ATR) is currently pointing at 0.20. The average price target for the stock over the next 12 months is $23, with the estimates having a low of $14 and a high of $38. These price ends are -673.48% and -1999.45% off the current price level respectively, although investors could be excited at the prospect of a -1170.72% if the ALXO share price touches on the median price of $23.
Coming back to Alx Oncology Holdings Inc (NASDAQ:ALXO), we note that the average 3-month trading volume was 962.90K, while that of the preceding 10-day period stands at 1.2 million. Current shares outstanding are 52.74 million.
The insiders hold 34.92% of the company’s shares while institutions hold 55.65%. The data shows that short shares as of 2024-12-13, stood at 8.39 million at a short ratio of 7.81. This represents a 2758.00 short interest in shares outstanding on 2024-12-13. Shares short rose in December from the previous month at 7.23 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 8.38% up in year-to-date price movement.
